Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Rachel J. Roth, … , Gerald I. Shulman, Anton M. Bennett
Rachel J. Roth, … , Gerald I. Shulman, Anton M. Bennett
Published November 16, 2009
Citation Information: J Clin Invest. 2009;119(12):3817-3829. https://doi.org/10.1172/JCI39054.
View: Text | PDF
Research Article Metabolism

MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice

  • Text
  • PDF
Abstract

Oxidative myofibers, also known as slow-twitch myofibers, help maintain the metabolic health of mammals, and it has been proposed that decreased numbers correlate with increased risk of obesity. The transcriptional coactivator PPARγ coactivator 1α (PGC-1α) plays a central role in maintaining levels of oxidative myofibers in skeletal muscle. Indeed, loss of PGC-1α expression has been linked to a reduction in the proportion of oxidative myofibers in the skeletal muscle of obese mice. MAPK phosphatase-1 (MKP-1) is encoded by mkp-1, a stress-responsive immediate-early gene that dephosphorylates MAPKs in the nucleus. Previously we showed that mice deficient in MKP-1 have enhanced energy expenditure and are resistant to diet-induced obesity. Here we show in mice that excess dietary fat induced MKP-1 overexpression in skeletal muscle, and that this resulted in reduced p38 MAPK–mediated phosphorylation of PGC-1α on sites that promoted its stability. Consistent with this, MKP-1–deficient mice expressed higher levels of PGC-1α in skeletal muscle than did wild-type mice and were refractory to the loss of oxidative myofibers when fed a high-fat diet. Collectively, these data demonstrate an essential role for MKP-1 as a regulator of the myofiber composition of skeletal muscle and suggest a potential role for MKP-1 in metabolic syndrome.

Authors

Rachel J. Roth, Annie M. Le, Lei Zhang, Mario Kahn, Varman T. Samuel, Gerald I. Shulman, Anton M. Bennett

×

Figure 6

MKP-1 antagonizes PGC-1α phosphorylation and protein stability.

Options: View larger image (or click on image) Download as PowerPoint
MKP-1 antagonizes PGC-1α phosphorylation and protein stability.
(A) Flag...
(A) Flag-tagged PGC-1α, MKK6EE, MKK7DD, and MKP-1 (10 μg) were transfected into C2C12 myoblasts. Myoblasts were lysed 24 hours later and immunoblotted with PGC-1α, MKP-1, phospho-p38 MAPK, p38 MAPK, phospho-JNK, and JNK antibodies. (B) Flag-tagged PGC-1α was transfected into C2C12 myoblasts along with nontargeting siRNA or MKP-1 siRNA as described in Figure 5B, and pulse-chase metabolic labeling with 35S methionine/cysteine was performed. Densitometric analyses were quantitated as the amount of PGC-1α remaining relative to time 0. The mean t1/2 was calculated from the linear regression derived from 3 independent experiments (nontargeting siRNA, 56.7 minutes; MKP-1 siRNA, 83.5 minutes; P < 0.05). Data are mean ± SEM. (C) Flag-tagged PGC-1α as well as Flag-tagged PGC-1α Ser265A and Thr298A mutants were transfected into C2C12 myoblasts with MKK6EE. Myoblasts were lysed, and PGC-1α was immunoprecipitated with anti-Flag antibodies and immunoblotted with total PGC-1α, phospho-Ser265 PGC-1α, or phospho-Thr298 PGC-1α antibodies. Lanes were run on the same gel but were noncontiguous (white line). (D) Flag-PGC-1α, MKK6EE, and MKP-1 (2 μg) were transfected into C2C12 myoblasts. Myoblasts were lysed, and PGC-1α was immunoprecipitated with anti-Flag antibodies and immunoblotted as in C. Graphs show densitometric measurements of phospho-Ser265 PGC-1α and phospho-Thr298 PGC-1α normalized to total PGC-1α from 3 independent experiments. Data are mean ± SEM. (E) Flag-tagged PGC-1α was transfected into C2C12 myoblasts along with 50 nM nontargeting or MKP-1 siRNA. Myoblasts were starved for 2 hours prior to stimulation with 10 ng/ml TNF-α and 2 ng/ml IL-1β for the indicated times. Myoblasts were lysed, and PGC-1α was immunoprecipitated with anti-Flag antibodies and immunoblotted as in C.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts